Green Light Testing

The ability to quickly identify viable lead vaccine candidates and advance them into preclinical trials is a huge advantage. Greenlight testing goes beyond in vitro tests to confirm efficacy early in the vaccine development process.

This stripped-down version of traditional animal-based studies delivers fast, meaningful results covering multiple factors in a fraction of the normal time – and for a relatively modest cost.

Call today to learn how BIOCON can help you identify which of your lead vaccine candidates produce the all-important immune response and deserve a “green light” for further development.